Journal
CIRCULATION
Volume 105, Issue 23, Pages 2708-2711Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.CIR.0000020548.60110.76
Keywords
atherosclerosis; imaging; nuclear medicine
Funding
- MRC [G9439390, G0001237] Funding Source: UKRI
- Medical Research Council [G0001237, G9439390] Funding Source: researchfish
- Medical Research Council [G0001237, G9439390] Funding Source: Medline
Ask authors/readers for more resources
Background-Atherosclerotic plaque rupture is usually a consequence of inflammatory cell activity within the plaque. Current imaging techniques provide anatomic data but no indication of plaque inflammation. The glucose analogue [F-18]-fluorodeoxyglucose ((18)FDG) can be used to image inflammatory cell activity non-invasively by PET. In this study we tested whether (18)FDG-PET imaging can identify inflammation within carotid artery atherosclerotic plaques. Methods and Results-Eight patients with symptomatic carotid atherosclerosis were imaged using (18)FDG-PET and co-registered CT. Symptomatic carotid plaques were visible in (18)FDG-PET images acquired 3 hours post-(18)FDG injection. The estimated net (18)FDG accumulation rate (plaque/integral plasma) in symptomatic lesions was 27% higher than in contralateral asymptomatic lesions. There was no measurable (18)FDG uptake into normal carotid arteries. Autoradiography of excised plaques confirmed accumulation of deoxyglucose in macrophage-rich areas of the plaque. Conchisions-This study demonstrates that atherosclerotic plaque inflammation can be imaged with (18)FDG-PET, and that symptomatic, unstable plaques accumulate more (18)FDG than asymptomatic lesions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available